Survival of Multiple Myeloma Patients Aged 65-70 Years in the Era of Novel Agents and Autologous Stem Cell Transplantation-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Survival of Multiple Myeloma Patients Aged 65-70 Years in the Era of Novel Agents and Autologous Stem Cell Transplantation

Published:2014 Issue:2 Volume:132 Page:211-219
ISSN:0001-5792
Container-title:Acta Haematologica
language:en
Short-container-title:Acta Haematol

Author:

Ozaki Shuji,Harada Takeshi,Saitoh Takayuki,Shimazaki Chihiro,Itagaki Mitsuhiro,Asaoku Hideki,Kuroda Yoshiaki,Chou Takaaki,Yoshiki Yumiko,Suzuki Kenshi,Murakami Hirokazu,Hayashi Kunihiko,Mina Roberto,Palumbo Antonio,Shimizu Kazuyuki,

Publisher

S. Karger AG

Subject

Hematology,General Medicine

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical significance of high-dose chemotherapy with autologous stem cell transplantation in the era of novel agents in patients older than 65 years with multiple myeloma;Annals of Hematology;2023-03-23

2. Novel Agents as Main Drivers for Continued Improvement in Survival in Multiple Myeloma;Cancers;2023-03-02

3. Tandem autologous stem cell transplantation in elderly patients with myeloma: A multicenter retrospective analysis;European Journal of Haematology;2023-01-17

4. The limited use of autologous hematopoietic stem cell transplant for fit older patients with multiple myeloma in India: a retrospective analysis;Journal of the Egyptian National Cancer Institute;2022-05-16

5. A bispecific CAR-T cell therapy targeting BCMA and CD38 in relapsed or refractory multiple myeloma;Journal of Hematology & Oncology;2021-10-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP